(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-3.29% INR 542.35
Live Chart Being Loaded With Signals
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India...
Stats | |
---|---|
Tagesvolumen | 200 303 |
Durchschnittsvolumen | 549 880 |
Marktkapitalisierung | 19.52B |
EPS | INR0 ( 2024-02-14 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-09 |
Last Dividend | INR3.00 ( 2021-08-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -6.33 |
ATR14 | INR1.013 (0.19%) |
Volumen Korrelation
Solara Active Pharma Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Solara Active Pharma Korrelation - Währung/Rohstoff
Solara Active Pharma Finanzdaten
Annual | 2022 |
Umsatz: | INR14.44B |
Bruttogewinn: | INR6.55B (45.37 %) |
EPS: | INR-6.16 |
FY | 2022 |
Umsatz: | INR14.44B |
Bruttogewinn: | INR6.55B (45.37 %) |
EPS: | INR-6.16 |
FY | 2022 |
Umsatz: | INR12.31B |
Bruttogewinn: | INR5.33B (43.29 %) |
EPS: | INR-16.22 |
FY | 2021 |
Umsatz: | INR16.17B |
Bruttogewinn: | INR8.47B (52.40 %) |
EPS: | INR69.00 |
Financial Reports:
No articles found.
Solara Active Pharma Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR5.00 | 2019-08-06 |
Last Dividend | INR3.00 | 2021-08-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | INR14.00 | -- |
Avg. Dividend % Per Year | 0.13% | -- |
Score | 0.73 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.727 | |
Div. Directional Score | 0.447 | -- |
Year | Amount | Yield |
---|---|---|
2019 | INR5.00 | 1.62% |
2020 | INR6.00 | 1.41% |
2021 | INR3.00 | 0.25% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
UBL.NS | Dividend Junior | 2023-08-03 | Annually | 17 | 0.27% | |
POLYCAB.NS | Dividend Knight | 2023-06-21 | Annually | 6 | 0.50% | |
JSL.NS | Dividend Junior | 2023-09-15 | Sporadic | 22 | 0.26% | |
DLF.NS | Dividend Junior | 2023-07-28 | Annually | 18 | 0.60% | |
AARON.NS | Dividend Junior | 2023-08-28 | Sporadic | 5 | 0.36% | |
SOUTHBANK.NS | Dividend Junior | 2023-08-17 | Sporadic | 25 | 0.42% | |
MONARCH.NS | Dividend Junior | 2023-09-14 | Annually | 3 | 0.20% | |
HERANBA.NS | Dividend Junior | 2023-08-17 | Annually | 4 | 0.20% | |
BHEL.NS | Dividend Junior | 2023-08-11 | Annually | 21 | 0.26% | |
RAMCOIND.NS | Dividend Junior | 2023-08-02 | Annually | 23 | 0.32% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.219 | 1.500 | -4.38 | -6.57 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.276 | 1.500 | -4.18 | -6.27 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -1.607 | 1.000 | -1.706 | -1.706 | [3 - 30] |
operatingCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.342 | 1.000 | 7.64 | 7.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.110 | 1.000 | -4.20 | -4.20 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.832 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -6.33 | 1.000 | -0.741 | 0 | [1 - 100] |
returnOnEquityTTM | -0.276 | 2.50 | -2.69 | -6.27 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.111 | 1.000 | 9.72 | 0 | [0.1 - 0.5] |
Total Score | 1.727 |
Solara Active Pharma
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.